アナフィラキシーにおける細胞内ヒスタミン濃度の減少と好塩基球活性の低下 by Yamaga, Satoshi
lable at ScienceDirect
Allergology International xxx (xxxx) xxxContents lists avaiAllergology International
journal homepage: ht tp: / /www.elsevier .com/locate/al i tOriginal ArticleDecreased intracellular histamine concentration and basophil
activation in anaphylaxis
Satoshi Yamaga a, Yuhki Yanase b, Kaori Ishii b, Shinichiro Ohshimo a, Nobuaki Shime a,
Michihiro Hide b, *
a Department of Emergency and Critical Care Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan
b Department of Dermatology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japana r t i c l e i n f o
Article history:
Received 9 February 2019
Received in revised form
18 May 2019
Accepted 21 May 2019
Available online xxx
Keywords:
Anaphylaxis
Basophil activation
CD203c
Intracellular histamine
Plasma histamine
Abbreviations:
AUC, area under the curve; CI, confidence
interval; EDTA, ethylenediaminetetraacetic
acid; FITC, fluorescein isothiocyanate;
HPLC, high performance liquid
chromatography; ICU, intensive care unit;
IQR, interquartile ranges; PBS, phosphate-
buffered saline; PC7, phycoerythrin
covalently linked to cyanine 7;
PE, phycoerythrin; ROC, receiver operating
characteristic; SD, standard deviation* Corresponding author. Department of Dermat
Biomedical & Health Sciences, Hiroshima Universit
Hiroshima 734-8551, Japan.
E-mail address: ed1h-w1de-road@hiroshima-u.ac.
Peer review under responsibility of Japanese Soci
https://doi.org/10.1016/j.alit.2019.05.009
1323-8930/Copyright © 2019, Japanese Society of Alle
licenses/by-nc-nd/4.0/).
Please cite this article as: Yamaga S et al., De
International, https://doi.org/10.1016/j.alit.2a b s t r a c t
Background: Histamine is a crucial mediator in the development of anaphylaxis. Although histamine is
promptly degraded because of its short half-life in plasma, basophils, which release histamine, remain in
the blood for days. To explore basophils as a potential marker and their involvement in the pathogenesis
of anaphylaxis, we evaluated the intracellular histamine concentration and the degree of basophil
activation in anaphylaxis patients.
Methods: We conducted a caseecontrol study enrolling anaphylaxis patients and healthy controls.
Basophil activation was evaluated by flow cytometry using up-regulation of CD203c expression.
Results: We enrolled 23 patients and measured their blood histamine concentration. Basophil activation
was analyzed in seven of 23 patients. The median intracellular histamine concentrations at admission
were significantly lower in patients compared with controls (16.4 ng/mL [interquartile range {IQR}, 2.70
to 34.0] vs. 62.3 ng/mL [IQR, 46.0 to 85.1]; p < 0.0001). The median basophil number at admission was
also significantly lower in patients compared with controls (2.21 cell/mL [IQR, 0.75 to 12.3] vs. 21.0 cell/mL
[IQR, 19.5 to 28.9]; p ¼ 0.027). CD203c expression was not up-regulated in any of the seven patients
in vitro, but it was up-regulated in response to anti-IgE stimulation in vitro in two patients at admission
and four patients at follow-up.
Conclusions: Anaphylaxis is associated with a decrease in intracellular histamine, and a reduced number
and reactivity of peripheral basophils. Impaired basophil function and a decrease in their number and
intracellular histamine levels in the circulation may reflect the underlying mechanism, suggesting that
basophils may be a marker of anaphylaxis.
Copyright © 2019, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Anaphylaxis is an acute life-threatening allergic response.1 It
may be caused either by immune mechanisms including type I
allergy, which is mediated by IgE, or a non-immune mechanism,
which directly activates mast cells or basophils.2 Regardless of the
trigger or mechanisms, chemical mediators released from mast
cells in tissues and basophils in the bloodstream are suspected to
play important roles in the development of anaphylaxis.3 Amongology, Graduate School of
y, 1-2-3 Kasumi, Minami-ku
jp (M. Hide).
ety of Allergology.
rgology. Production and hosting by Else
creased intracellular histami
019.05.009the mediators, histamine induces vasodilatation, increases vascular
permeability,4,5 causes tachycardia, and decreases blood pressure.6
Moreover, the plasma concentration of histamine may reflect the
severity of anaphylaxis.7 However, histamine released into the
peripheral blood circulation is rapidly hydrolyzed by histamine
methyltransferase and its half-life in plasma is only a fewminutes.8
Laroche et al.8 demonstrated that the increase in plasma hista-
mine level can be detected in 10 out of 19 patients with anaphy-
laxis. Robert et al.9 showed that the increase in plasma histamine
level was observed in 47% of patients who presented to the emer-
gency department with acute allergic reactions. However, the half-
life of basophils is 2e3 days, and the decrease in the amount of
intracellular histamine caused by basophil degranulation is not
restored immediately. Thus, the amount of intracellular histamine
may reflect basophil degranulation in the blood for a few days aftervier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1
Clinical characteristics of the enrolled patients.
Variables Anaphylaxis Control
Number of patients 23 23
Age, yr 56.5 ± 16.4 56.9 ± 17.3
Male sex, n (%) 16 (70) 16 (70)
Out of hospital/In hospital 9/14
Past history of anaphylaxis, n (%) 2 (10)
Cause of anaphylaxis, n (%)
Drugs 17 (74)
Foods 4 (17)
Insect sting 1 (4)
FDEIA 1 (4)
Risk Factors, n (%)
Comorbidities
Cancer 11 (48)
Cardiovascular disease 4 (17)
Acute infection 3 (13)
COPD 1 (4)
Drug
NSAIDs 1 (4)
Allergic predisposition 9 (39)
Treatments, n (%)
Adrenaline (intramuscular injection) 18 (78)
H1 and/or H2 antihistamines 22 (96)
Corticosteroids 17 (74)
Vasopressors 11 (48)
Mechanical ventilation 2 (9)
FDEIA, food dependent exercise induced anaphylaxis; COPD, chronic obstructive
pulmonary disease; NSAIDs, non-steroidal anti-inflammatory drugs.
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ated by the level of cell surface protein, such as CD203c and CD63.
In this study, we investigated the level of intracellular histamine
and cell surface CD203c in basophils and their reactivity compared
with clinical characteristics of basophil donors, to explore the po-
tential of basophils as a marker and their involvement in the
pathogenesis of anaphylaxis.
Methods
Study design
We conducted a caseecontrol study in the emergency and
critical care center and intensive care unit (ICU) of Hiroshima
University Hospital. We recruited patients with anaphylaxis whose
plasma and total histamine concentrations could be measured. The
criteria for anaphylaxis was adopted from the 2006 National
Institute of Allergy and Infectious Disease/Food Allergy and
Anaphylaxis Network meeting.1 The severity of anaphylaxis was
classified based on the classification recommended by Brown
et al.10 Patient information including causes of anaphylaxis, medical
history, clinical symptoms, plasma and total histamine concentra-
tions in blood, disease severity, medications, and outcomes were
collected and analyzed together with the number, activity, and
activation capacity of basophils in blood. We also collected blood
samples from age and sex-matched controls, who visited outpa-
tient clinic or worked in the hospital for the levels of plasma and
whole blood histamine. This study was approved by the ethics
committee for epidemiology of Hiroshima University. All the par-
ticipants provided written informed consent to enroll in this study
and to obtain blood samples.
Measurement of histamine concentrations in whole blood and
plasma
Blood samples were collected from patients with anaphylaxis
and healthy controls at admission and on the next day (follow up).
Ethylenediaminetetraacetic acid (EDTA)-treated peripheral whole
blood was immediately stored in a refrigerator (4 C) until analysis.
The samples of whole blood and plasma were mixed with HClO4 to
a final concentration of 2.5% HClO4 to denature excess protein,
followed by incubation for 30 min, and then histamine was
extracted by centrifugation. The amounts of histamine were
measured using high performance liquid chromatography (HPLC),
as described previously.11 The HPLC system consisted of an LC-4A
(Shimadzu, Kyoto, Japan) with an RF-535 fluorescence monitor
(Shimadzu) operating at an emission wavelength of 450 nm and an
excitation wavelength of 350 nm. The levels of intracellular hista-
mine were determined as the difference between the levels of
histamine in whole blood and those in plasma.
Flow cytometry analysis for evaluating basophil count and activity
Basophil counts and its activity were evaluated by flow cytom-
etry using the Allergenicity® kit (Beckmann Coulter, Brea, CA, USA),
in accordance with the manufacturer's instructions. The cells in
EDTA-treated peripheral whole blood obtained from patients with
anaphylaxis were stained with fluorescein isothiocyanate (FITC)-
labeled anti-CRTH2 antibody, phycoerythrin (PE)-labeled anti-
CD203c antibody, and phycoerythrin covalently linked to cyanine
7 (PC7)-labeled anti-CD3 (Beckmann Coulter) for 15 min at 37 C
while being protected from light on water bath. Erythrocytes were
lysed with lysing solution provided in the kit. After washing twice
with phosphate-buffered saline (PBS), the stained cells were
analyzed using an Attune® acoustic focusing cytometer (ThermoPlease cite this article as: Yamaga S et al., Decreased intracellular histami
International, https://doi.org/10.1016/j.alit.2019.05.009Fisher Scientific, Waltham, MA, USA). Basophils can be identified by
CRTH2 and CD203c double-positive and CD3 negative cells. The
basophil activation level was evaluated by analyzing the increase in
CD203c expression. To evaluate the capacity of basophils to
respond, we stimulated basophils with anti-human IgE reagent,
whichwas prepared using the Allergenicity® kit. We alsomeasured
the number of basophils in healthy controls using the same pro-
tocols. The measurement of plasma andwhole blood histamine and
flow cytometry analysis were conducted at admission and the next
morning as a follow-up.
Statistical analysis
We reported continuous variables as the mean and standard
deviation (SD) or the median and interquartile range (IQR), and
categorical variables as proportions. We used the Wilcoxon rank-
sum test to compare continuous variables. Analysis of the
receiver operating characteristic (ROC) curve and calculation of the
area under the curve (AUC) was used to assess the diagnostic ac-
curacy of plasma and intracellular histamine levels for anaphylaxis.
All analyses were conducted using JMP 12 software (SAS Institute,
Cary, NC, USA). A two-sided p-value <0.05 was considered to
indicate statistical significance.
Results
Study subjects
We enrolled 23 patients with anaphylaxis who had their levels
of plasma and whole blood histamine were measured. Table 1
shows the baseline characteristics of the patients enrolled. Drugs
are the most frequent cause of anaphylaxis (74%). The top two
drugs that were suspected to cause anaphylaxis were radio-
contrast media in seven cases, and anticancer drugs in four cases.
Twenty-one (91%) patients were classified with severe anaphy-
laxis (Table 2).ne concentration and basophil activation in anaphylaxis, Allergology
Table 2
Clinical symptoms at the onset of anaphylaxis.
n (%)
Skin, subcutaneous tissue, and mucosa
Erythema 19 (83)
Urticaria 6 (26)
Periorbital edema 3 (13)
Swelling of lips and/or tongue 3 (13)
Pruritus 3 (13)
Respiratory
Dyspnea 10 (43)
Hypoxemia (SpO2<92%) 8 (35)
Edema of larynx 2 (9)
Cough 1 (4)
Hoarseness 1 (4)
Stridor 1 (4)
Cardiovascular and central nervous system
Hypotension 21 (91)
Decrease levels of CNS 12 (52)
Syncope 5 (22)
Convulsion 1 (4)
Abdominal
Diarrhea 4 (17)
Nausea 3 (13)
Vomiting 3 (13)
Cardiopulmonary arrest 1 (4)
Severity of anaphylaxis
Mild 0 (0)
Moderate 2 (9)
Severe 21 (91)
CNS, central nervous system.
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The median plasma histamine level in patients with anaphy-
laxis at admission was 8.24 ng/mL (IQR, 3.06 to 27.7), which
tended to be higher than that in healthy controls (5.02 ng/mL;
IQR, 2.32 to 8.45; p ¼ 0.0588; Fig. 1A). The median plasma hista-
mine level in patients with anaphylaxis at follow-up was 0.19 ng/
mL (IQR, 0 to 1.83), which was significantly lower than that in
healthy controls (p ¼ 0.0005; Fig. 1A). The median intracellular
histamine level was significantly lower in patients with anaphy-
laxis at admission compared with healthy controls (16.4 ng/mL
[IQR, 2.70 to 34.0] vs. 62.3 ng/mL [IQR, 46.0 to 85.1]; p < 0.0001;
Fig. 1B). The median intracellular histamine level in patients withFig. 1. Histamine levels. Box plot graphs showing the plasma histamine ranges (A); intrace
morning), and in controls. NS, nonsignificant; *p < 0.05 (significantly different from contro
Please cite this article as: Yamaga S et al., Decreased intracellular histami
International, https://doi.org/10.1016/j.alit.2019.05.009anaphylaxis at follow-up (9.44 ng/mL; IQR, 2.29 to 24.3) was also
significantly lower compared with controls (p < 0.0001; Fig. 1B).
The ROC curves for intracellular and plasma histamine levels for
detecting anaphylaxis revealed sensitivities of 78.3% (95% confi-
dence interval [CI], 61.4 to 95.1) and 60.9% (95% CI, 40.9 to 80.8)
and specificities of 87.0% (95% CI, 73.2 to 100) and 65.2% (95% CI,
45.8 to 84.7) at cutoff values of 34.0 ng/mL for intracellular his-
tamine and 5.35 ng/mL for plasma histamine, respectively. The
AUC of intracellular histamine levels was significantly higher than
that of plasma histamine (0.93 [95% CI, 0.83 to 0.97] vs. 0.66 [95%
CI, 0.49 to 0.80]; p ¼ 0.0043; Fig. 2).
Number of basophils
Basophil counts and its activity were evaluated in seven of 23
patients. The median number of basophils was significantly lower
in patients with anaphylaxis at admission (2.21 cell/mL; IQR, 0.75 to
12.3) compared with controls (21.0 cell/mL; IQR, 19.5 to 28.9;
p ¼ 0.0266; Fig. 3A). A further decline in the median number of
basophils in patients with anaphylaxis was observed at follow-up
(1.00 cell/mL; IQR, 0.75 to 5.37), which was also lower than that in
controls (p ¼ 0.0034, Fig. 3A).
Intracellular histamine per cell and basophil activation
There was no significant difference between the median intra-
cellular histamine per cell in patients with anaphylaxis at admis-
sion (1.34 pg/cell; IQR, 0 to 4.37) and that in controls (2.95 pg/cell;
IQR, 2.76 to 3.10; p ¼ 0.224; Fig. 3B). There was also no significant
difference between the median intracellular histamine levels per
cell in patients with anaphylaxis at follow-up (1.89 pg/cell; IQR, 0 to
2.91) and that in controls (p ¼ 0.0999; Fig. 3B).
We conducted flow cytometry analysis to evaluate CD203c
expression, which is a marker of basophil activation, in seven pa-
tients (Table 3). There was no up-regulation of CD203c in all seven
patients at admission. After anti-IgE stimulation, an increase in
CD203c levels was observed in two patients (29%) at admission and
four patients (57%) at follow-up. Representative dot plots of CD203c
expression levels are shown in Supplementary Figure 1.
Four patients with anaphylaxis who showed an increase in
CD203c levels at follow-up in response to anti-IgE antibody stim-
ulation also showed an increase in intracellular histamine per cell.llular histamine (B) in patients with anaphylaxis at admission and at follow-up (next
l by Wilcoxon rank-sum test).
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Fig. 2. Receiver operating characteristic curves for detecting anaphylaxis. The solid line
indicates intracellular histamine levels with an area under the curve (AUC) of 0.93 [95%
confidence interval (CI), 0.83e0.97], and the dotted line indicates plasma histamine
levels with an AUC of 0.66 [95%CI, 0.49e0.80] for detecting anaphylaxis.
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further in three patients who did not respond to anti-IgE antibody
(Table 3). The intracellular histamine levels per cell in these pa-
tients also remained low at follow-up compared with those at
admission (Table 3).Discussion
To the best of our knowledge, this is the first study that showed
decreased intracellular histamine levels and decreased basophil
counts in peripheral blood in patients with anaphylaxis compared
with controls. The number of basophils remained decreased during
follow-up the next day. However, there was no significant differ-
ence in plasma histamine levels between patients with anaphylaxisFig. 3. Basophil number and intracellular histamine per cell. Box plot graphs showing basop
admission and at follow-up (next morning), and in controls. NS, nonsignificant; *p < 0.05 (
Please cite this article as: Yamaga S et al., Decreased intracellular histami
International, https://doi.org/10.1016/j.alit.2019.05.009and healthy controls. Additionally, no patients with anaphylaxis
demonstrated basophil activation in the peripheral blood, regard-
less of the amount of intracellular histamine per cell.
Van der Linden et al.12 demonstrated that the plasma histamine
levels in patients with anaphylaxis were significantly higher than
those in healthy controls. However, plasma histamine levels in as-
sociation with symptoms should be measured within 1 h after the
onset of the symptoms because of the short half-life of histamine in
circulation.3,8 They included anaphylaxis in patients in response to
the insect-sting challenge test, and strictly controlled the timing of
blood sampling from the onset of anaphylaxis. However, in real-
world clinical practice, it is difficult to define blood sample
timing, which may largely affect the measured plasma histamine
level. In this study, we found no statistical difference in the levels of
plasma histamine between patients and healthy control subjects.
Because approximately 40% of patients analyzed in this report were
outpatients, it is likely that a large part of histamine in the blood
circulation had been degraded before sampling.
The intracellular histamine level in patients with anaphylaxis
was significantly lower, both at admission and during the follow-up
period compared with healthy controls. The causes of anaphylaxis
varied in patients in this study, including non-immunologic agents,
such as radiocontrast medium and anticancer drugs, which sug-
gests that intracellular histamine can be a useful biomarker
regardless of the patient's allergic predisposition.
Previous studies demonstrated that the number of basophils in
the peripheral blood also decreased in chronic idiopathic/sponta-
neous urticaria (CSU).13,14 There was a significant negative corre-
lation between basophil numbers and urticarial activities.14
Moreover, the decrease in the peripheral basophil numbers was
reversed in association with clinical improvement by treatments
with corticosteroids14 or omalizumab15 in CSU. However, no studies
have investigated the kinetics of peripheral blood basophils in
anaphylaxis. Both anaphylaxis and urticaria develop erythema and
wheals, which are induced by the release of chemical mediators
including histamine from basophils and mast cells. In type I allergy,
basophils and mast cells are sensitized by IgE binding to their high
affinity IgE receptors (FcεRI) on the cell surface causing the release
mediators, such as histamine, leukotriene, and tryptase in response
to cross-linkage of FcεRI by the binding of specific antigens to IgE.
The CD63 level, another marker of basophil activation, was upre-
gulated in the blood of patients with CSU.16 However, no patientshil number (A), and intracellular histamine per cell (B) in patients with anaphylaxis at
significantly different from control by Wilcoxon rank-sum test).
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Table 3
Intracellular histamine concentration and basophil activation.
Patient
No
Cause of anaphylaxis Intracellular histamine
per cell (pg/cell)
Basophil number (/mL) Activation of peripheral blood basophils (up-regulation of CD203c
expression)
At admission Follow -up At admission Follow -up At admission vehicle At admission anti-IgE Follow-up vehicle Follow-up anti-IgE
1 Anticancer drug 4.73 0 4.20 0.75 non-reactive non-reactive non-reactive non-reactive
2 Anticancer drug 4.37 0.31 0.75 0.78 non-reactive non-reactive non-reactive non-reactive
3 Radiocontrast media 1.34 0 32.5 1.00 non-reactive non-reactive non-reactive non-reactive
4 Radiocontrast media 0 7.25 1.99 5.45 non-reactive non-reactive non-reactive reactive
5 Radiocontrast media 0 1.90 0.07 5.37 non-reactive non-reactive non-reactive reactive
6 Radiocontrast media 1.35 2.26 12.3 3.85 non-reactive reactive non-reactive reactive
7 Radiocontrast media 0.73 2.91 2.21 0.83 non-reactive reactive non-reactive reactive
IgE, immunoglobulin E.
S. Yamaga et al. / Allergology International xxx (xxxx) xxx 5with anaphylaxis showed basophil activation in the peripheral
blood in this study. Moreover, only two of seven patients showed
the potential for basophil activation in response to anti-IgE stim-
ulation. The discrepancy between basophil activation in CSU and
that in anaphylaxis in this study remains controversial. This may be
because of the low sensitivity of CD203c compared with CD63.
There was no difference in CD203c expression between basophils
from patients with CSU and those from healthy controls.16 Themost
possible explanation is that the activated basophils had migrated
out of the peripheral blood into the tissue, and that residual
immature basophils that contain only a small amount of histamine
and cannot respond to crosslinkage of FcεRI by anti IgE in the pe-
ripheral blood of patients with anaphylaxis. Mukai et al. demon-
strated, using a mouse model of chronic allergy, that peripheral
basophils can migrate to the tissue.17 Increased basophil infiltration
was also observed in lungs and bronchial tissue of postmortem
patients with fatal asthma compared with non-asthmatic fatal
cases.18 The increase in the basophil activation capability on follow-
up in two patients (Numbers 4 and 5) might have been associated
with the new recruitment of mature basophils, possibly from bone
marrow, which was suggested by the increase in basophil number.
Although there is a possibility that the basophils of patients with
anaphylaxis have been already activated enough before the baso-
phil activation test, the result that there was no patient with an
increase in CD203c levels at admission may suggest that immature
basophils, which were not capable of responding to anti-IgE stim-
ulus, remained in the peripheral blood.
There are several limitations in our study. First, flow cytometry
analysis should be performed within a few hours after blood
sampling. There could be a selection bias toward patients in whom
flow cytometry analysis was immediately possible. All patients in
whom flowcytometry analysis could be performedwere inpatients.
Second, previous studies showed that anaphylactic patients with
hypotension and impaired consciousness accounted for 9.2e21.6%
and 2.8e15.2% of patients, respectively.19,20 In our study, patients
with hypotension and impaired consciousness accounted for more
than 90% and 50% of patients, respectively, suggesting that the
patients’ symptoms in this study are more severe than those in
previous studies. Third, we assigned healthy volunteers to the
control group. To determine whether intracellular histamine levels
are useful to differentiate anaphylaxis from non-anaphylactic pa-
tients, further studies including a control group comprising non-
anaphylactic patients with similar symptoms to anaphylaxis, such
as hypotension or impaired consciousness, should also be studied.
Fourth, up-regulation of CD203c on the surface of basophils of each
patient was evaluated manually, because we enrolled the patients
who already developed anaphylaxis and could not analyze unsti-
mulated cells before the onset of anaphylaxis to define the
threshold of CD203c up-regulation. Finally, we did not analyze our
results based on stratification by the severity of anaphylaxisPlease cite this article as: Yamaga S et al., Decreased intracellular histami
International, https://doi.org/10.1016/j.alit.2019.05.009because of the small sample size in this study. The analysis of
basophil counts in peripheral blood were performed only in seven
patients with anaphylaxis. Further prospective studies with a larger
sample size are needed to validate our results.
In conclusion, we found a decrease in the level of intracellular
histamine and the number of basophils and their reactivity to an
anti-IgE stimulus in the blood of patients with anaphylaxis. These
results suggest a crucial role for basophils in the mechanism of
anaphylaxis, regardless of the involvement of type I allergy.Acknowledgements
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